Megan Barnden - Concepedia

Concepedia

Author

Megan Barnden

CSL (Australia)

Also Known As

Barnden, Megan Jane, M. J. Barnden, Megan Barnden, Megan J Barnden, Megan J. Barnden

17

Publications

2.9K

Citations

15

H-Index

34

Concepts

All Affiliations

CSL (Australia)Walter and Eliza Hall Institute of Medical Research The Royal Melbourne Hospital Monash Medical Centre The University of Melbourne

MB

About

Megan Barnden is an author at CSL (Australia) specializing in medicine, vaccine development, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	205
2	Natural Sciences	1	1	95
3	Public Health	1	1	24
4	Allergy	1	1	28
5	Biochemistry	1	1	95

Megan Barnden

×

15

Publications

2.9K

Citations

15

H-Index

	Year	Citations
Defective TCR expression in transgenic mice constructed using cDNA‐based α‐ and β‐chain genes under the control of heterologous regulatory elements Megan Barnden, Jan Allison, William R. Heath Immunology and Cell Biology	1998	1.5K
CD4+ T Cell Help Impairs CD8+ T Cell Deletion Induced by Cross-presentation of Self-Antigens and Favors Autoimmunity Christian Kurts, Megan Barnden, Effrossini Blanas, The Journal of Experimental Medicine	1997	316
Characterization of the ovalbumin‐specific TCR transgenic line OT‐I: MHC elements for positive and negative selection Sally R. M. Clarke, Megan Barnden, Christian Kurts, Immunology and Cell Biology	2000	296
HLA-B27–Restricted Antigen Presentation in the Absence of Tapasin Reveals Polymorphism in Mechanisms of HLA Class I Peptide Loading Chen Au Peh, Scott R. Burrows, Megan Barnden, Immunity	1998	253
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia Simon He, Samantha J. Busfield, David Ritchie, Leukemia & lymphoma/Leukemia and lymphoma	2014	122
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX™ vaccine: A phase I study in healthy volunteers Debbie Drane, Eugene Maraskovsky, Rebecca A. Gibson, Human Vaccines	2009	112
Tapasin-Mediated Retention and Optimization of Peptide Ligands During the Assembly of Class I Molecules Megan Barnden, Anthony W. Purcell, Jeffrey J. Gorman, The Journal of Immunology Peptide EngineeringMolecular BiologyAntigen ProcessingCellular PhysiologyTapasin-mediated Retention	2000	95
First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse B. Douglas Smith, Gail J. Roboz, Roland B. Walter, Blood	2014	60
A Randomized, Placebo-Controlled, Dose-Escalation Study to Determine the Safety, Tolerability, and Immunogenicity of an HPV-16 Therapeutic Vaccine in HIV-Positive Participants With Oncogenic HPV Infection of the Anus J. Anderson, Jennifer Hoy, Richard J. Hillman, JAIDS Journal of Acquired Immune Deficiency Syndromes	2009	39
Down-Modulation of CD8 β-Chain in Response to an Altered Peptide Ligand Enables Developing Thymocytes to Escape Negative Selection Megan Barnden, William R. Heath Cellular Immunology Signal TransductionLymphocyte DevelopmentImmune Cell DevelopmentCd8 β-ChainImmunology	1997	35

Page 1